-
EVMPs for Extrahepatic mRNA Delivery
2026-09-05
The reference study presents a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) designed to overcome the liver bias of many mRNA delivery systems. By combining an engineered virus-mimicking peptide with tunable phospholipid envelopes, the authors achieved targeted delivery to lung and spleen tissues and demonstrated therapeutic activity with IL-12 mRNA in a metastatic lung tumor model.
-
Temafloxacin Pharmacokinetics: Key Findings
2026-09-04
Dudley’s 1991 review integrates absorption, distribution, elimination, renal function, and pharmacodynamic considerations for temafloxacin, showing high oral bioavailability, an approximately 8-hour half-life, and substantial tissue distribution. These findings support simplified dosing while illustrating how pharmacokinetic evidence can guide interval adjustment and translational antimicrobial research.
-
One-step TUNEL FITC: From Signal to Mechanism
2026-09-04
The One-step TUNEL FITC Apoptosis Detection Kit connects DNA fragmentation with mechanistic toxicology, offering a practical framework for interpreting apoptosis signals in environmental reproductive research. Learn how to pair FITC-labeled dUTP incorporation with tissue localization, flow cytometry, and omics-derived hypotheses.
-
Exendin-4 Workflows for Beta Cell Research
2026-09-03
Build reproducible Exendin-4 and Exenatide experiments around cAMP, insulin secretion, and proinsulin transcription rather than relying on a single endpoint. This guide connects beta-cell assays with metabolic models, yeast-based production research, and practical troubleshooting for type 2 diabetes research.
-
Niclosamide: From STAT3 Biology to Translational Strategy
2026-09-03
Niclosamide offers translational researchers a practical bridge between STAT3 pathway interrogation, phenotype-driven cancer research, and disciplined cross-domain evaluation. This thought-leadership guide connects mechanism, assay design, formulation, in vivo evidence, and ecological context while distinguishing established findings from forward-looking workflow recommendations.
-
7-Ethyl-10-hydroxycamptothecin: Assay Logic
2026-09-02
7-Ethyl-10-hydroxycamptothecin, also known as SN-38, is more than a topoisomerase I inhibitor. This article presents a mechanism-resolved assay framework that separates DNA replication stress, cell-cycle effects, apoptosis, and FUBP1/FUSE transcriptional disruption in advanced colon cancer research.
-
X-Gal: From Molecular Cloning to Translational Biology
2026-09-02
X-Gal is more than a blue-white colony screening reagent: it is a mechanistically transparent way to connect construct integrity with reporter biology. This article examines how 5-bromo-4-chloro-indolyl-β-D-galactopyranoside can support disciplined translational workflows, while using recent iRhom2 olfaction research to define both the opportunity and the boundaries of cross-domain application.
-
Dual Recombinase Tracing Rules Out Mouse Neo-Oogenesis
2026-09-01
Xie, Zhou, and Zheng used orthogonal Cre-loxP and Dre-rox lineage tracing to test whether non-germ ovarian cells generate new oocytes after birth. Across physiological aging and busulfan-induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the conclusion that postnatal neo-oogenesis does not occur in vivo in mice.
-
Cefepime (BMY-28142) in Resistance-Aware Assays
2026-08-31
Cefepime (BMY-28142) can do more than serve as a beta-lactam challenge in bacterial infection models. This article presents a resistance-aware assay framework that connects cefepime phenotype, carbapenemase gene localization, plasmid transfer, and CNS infection research without confusing in vitro findings with clinical conclusions.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-08-31
Yin et al. identify a brain-to-spinal opioid circuit linking MOR-expressing neurons in the lateral parabrachial nucleus, dynorphin neurons in the paraventricular hypothalamus, and KOR-expressing GABAergic neurons in the spinal dorsal horn. Their mouse experiments show that disrupting this pathway can alleviate morphine-induced mechanical hypersensitivity and analgesic tolerance, clarifying a central mechanism relevant to opioid receptor pharmacology and chronic pain research.
-
Separating Growth Inhibition from Cancer Cell Death
2026-08-30
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for distinguishing proliferative arrest from cell killing and for interpreting their different magnitudes and time courses in cancer research.
-
PDGF-BB Murine Recombinant Protein for Cell Assays
2026-08-29
PDGF-BB is a recombinant homodimeric growth factor used to stimulate receptor-dependent cell proliferation. Murine recombinant PDGF-BB provides defined structural, purity, endotoxin, reconstitution, and activity specifications for controlled in-vitro assays, including smooth muscle cell proliferation studies.
-
Cell lysis buffer for WB and IP: Lab Guide
2026-08-29
Learn how Cell lysis buffer for WB and IP (SKU K1123) supports reproducible protein extraction for Western blotting, immunoprecipitation, and signaling studies. This scenario-based guide connects inhibitor selection and non-denaturing lysis to investigations of cancer-associated fibroblasts, mitochondrial metabolism, and chemoresistance.
-
Bi-Layer Tranexamic Acid Dressings for Trauma Hemostasis
2026-08-28
This 2024 study presents a bi-layer wound dressing that combines Tranexamic Acid, nitric oxide release, and propolis to address rapid hemorrhage control and bacterial contamination in trauma. Early platelet-associated clot formation, dense fibrin architecture, and substantial reductions in bacterial colony counts support the design as a promising research platform, although further in vivo and translational validation is needed.
-
From Fluorescent RNA to In Situ TIL Translation
2026-08-28
Cy5-UTP turns RNA probe synthesis into a strategic assay for tracking delivery, localization, and expression in translational immunology. By connecting Cyanine 5-uridine triphosphate with the in situ TIL therapy framework reported in ACS Nano, this article shows how fluorescent RNA labeling can strengthen preclinical decision-making while clarifying the boundaries between an analytical surrogate and a therapeutic mRNA.